104 related articles for article (PubMed ID: 1671961)
1. Medical audit, cancer registration, and survival in ovarian cancer.
Gillis CR; Hole DJ; Still RM; Davis J; Kaye SB
Lancet; 1991 Mar; 337(8741):611-2. PubMed ID: 1671961
[No Abstract] [Full Text] [Related]
2. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
Paulsen T; Kjaerheim K; Kaern J; Tretli S; Tropé C
Int J Gynecol Cancer; 2006; 16 Suppl 1():11-7. PubMed ID: 16515561
[TBL] [Abstract][Full Text] [Related]
3. Use of cancer registry data to evaluate the treatment of ovarian cancer on a hospital basis.
Hole DJ; Gillis CR
Health Rep; 1993; 5(1):117-9. PubMed ID: 8334233
[No Abstract] [Full Text] [Related]
4. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit.
Kirwan JM; Tincello DG; Herod JJ; Frost O; Kingston RE
BMJ; 2002 Jan; 324(7330):148-51. PubMed ID: 11799032
[TBL] [Abstract][Full Text] [Related]
5. [Survival of gynecological cancer patients in Osaka, Japan].
Ioka A; Ajiki W; Tsukuma H; Oshima A
Nihon Rinsho; 2004 Oct; 62 Suppl 10():49-54. PubMed ID: 15535204
[No Abstract] [Full Text] [Related]
6. More up-to-date monitoring of long-term survival rates by cancer registries: an empirical example.
Brenner H; Gefeller O; Stegmaier C; Ziegler H
Methods Inf Med; 2001 Jul; 40(3):248-52. PubMed ID: 11501640
[TBL] [Abstract][Full Text] [Related]
7. Cancer registration: principles and methods. Analysis of survival.
Parkin DM; Hakulinen T
IARC Sci Publ; 1991; (95):159-76. PubMed ID: 1894319
[No Abstract] [Full Text] [Related]
8. Misstaging of ovarian cancer.
McGowan L; Lesher LP; Norris HJ; Barnett M
Obstet Gynecol; 1985 Apr; 65(4):568-72. PubMed ID: 3982731
[TBL] [Abstract][Full Text] [Related]
9. [CA 125 in diagnosis and prognosis of epithelial ovarian cancer].
Cohen AD; Piura B; Cohen Y; Shoenfeld Y
Harefuah; 1994 Mar; 126(5):283-5, 303. PubMed ID: 8188111
[TBL] [Abstract][Full Text] [Related]
10. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.
Nagase S; Ohta T; Takahashi F; Enomoto T;
J Obstet Gynaecol Res; 2019 Feb; 45(2):289-298. PubMed ID: 30426591
[TBL] [Abstract][Full Text] [Related]
11. Survival of BRCA1 negative ovarian cancer patients based on family history.
Chu CS; Morgan MA; Randall TC; Bandera CA; Rubin SC
Gynecol Oncol; 2001 Oct; 83(1):109-14. PubMed ID: 11585421
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival for breast cancer patients with a BRCA1 mutation.
Narod SA; Huzarski T; Gronwald J; Byrski T; Marczyk E; Cybulski C; Szwiec M; Wisniowski R; Birkenfeld B; Kilar E; Sibilski R; Sun P; Lubinski J
Breast Cancer Res Treat; 2018 Apr; 168(2):513-521. PubMed ID: 29247441
[TBL] [Abstract][Full Text] [Related]
13. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
14. Active specific immunotherapy for ovarian cancer.
Hudson CN; McHardy JE; Curling OM; English PE; Levin L; Poulton TA; Crowther M; Leighton M
Lancet; 1976 Oct; 2(7991):877-9. PubMed ID: 62114
[TBL] [Abstract][Full Text] [Related]
15. Five-year relative survival rate of ovarian cancer in the USA, Europe and Japan.
Matsuda A; Katanoda K
Jpn J Clin Oncol; 2014 Feb; 44(2):196. PubMed ID: 24496206
[No Abstract] [Full Text] [Related]
16. Hospital pharmacists' participation in audit in the United Kingdom.
Cotter S; McKee M; Barber N
Qual Health Care; 1993 Dec; 2(4):228-31. PubMed ID: 10132456
[TBL] [Abstract][Full Text] [Related]
17. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
Timmermans M; Sonke GS; Van de Vijver KK; van der Aa MA; Kruitwagen RFPM
Eur J Cancer; 2018 Jan; 88():31-37. PubMed ID: 29179135
[TBL] [Abstract][Full Text] [Related]
18. [Registration of gynecologic malignancy in Japan].
Kasamatsu T
Nihon Rinsho; 2012 Jun; 70 Suppl 4():29-33. PubMed ID: 23156213
[No Abstract] [Full Text] [Related]
19. The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Rouzier R; Bergzoll C; Brun JL; Dubernard G; Selle F; Uzan S; Pomel C; Daraï E
BJOG; 2010 Nov; 117(12):1451-8. PubMed ID: 20560944
[TBL] [Abstract][Full Text] [Related]
20. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
